Discover companies at the forefront of medical breakthroughs and healthcare innovation. This collection of biotech stocks has been carefully selected by our professional analysts for their growth potential and contributions to revolutionary treatments.
These companies are developing treatments that could transform healthcare as we know it. From gene editing to novel therapies, they're tackling our biggest health challenges.
The biotech industry is projected to grow at nearly 14% annually through 2030. Getting in now means positioning yourself at the start of what could be a remarkable expansion.
By investing in biotech, you're not just seeking returns but also supporting companies developing treatments that could save millions of lives and improve countless others.
These biotech companies are pioneering revolutionary treatments using advanced technologies like CRISPR gene editing. With favorable regulatory environments expediting approvals and growing global demand for innovative healthcare solutions, this sector offers both meaningful impact and promising financial growth opportunities.
Biotech investments can offer substantial returns but typically involve longer development cycles. The industry is projected to grow from $1.55 trillion in 2023 to approximately $3.88 trillion by 2030, with regulatory support accelerating the approval of promising treatments.
We've selected established biotech leaders and innovative disruptors working on groundbreaking medical advancements. These companies are well-positioned to respond to increasing healthcare demands as global populations age, making them potentially valuable additions to a forward-looking investment portfolio.
Summary and key takeaways for a basket of top biotech stocks based on provided market capitalisation data.
AMGN: $162.12B
GILD: $153.96B
BIIB: $21.44B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Home Depot's recent earnings beat highlights consistent consumer spending on smaller household repair and maintenance projects. This ongoing trend presents promising opportunities for various home improvement retailers and building material suppliers.
BHP Group recently posted a massive earnings beat driven by record copper profitability, allowing the miner to raise its dividend to a four-year high. This performance highlights a structural shift toward electrification metals, creating opportunities for industrial equipment suppliers and competing copper producers.
Here are a few of the assets in this group. Create an account to unlock the full list.
Unlock all stocks by downloading the app for FREE
It only takes 60 seconds.
On average, analysts expect assets in this group to grow 102.89% over the next year.
5 of 8 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+102.89%
